ReviewAdvances in therapy2014

Pathophysiological and pharmacological rationale for the use of exenatide once weekly in patients with type 2 diabetes.

Samuel S GrossmanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.